Market Tracker

09/30 5:52am ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

69.94
Delayed Data
As of Sep 29
 -6.73 / -8.78%
Today’s Change
49.96
Today|||52-Week Range
110.75
-25.71%
Year-to-Date

Today’s Trading

Previous close76.67
Today’s open75.00
Day’s range69.77 - 75.35
Volume1,378,031
Average volume (3 months)791,397
Market cap$6.6B
Dividend yield--
Data as of 09/29/2016

Growth & Valuation

Earnings growth (last year)+28.87%
Earnings growth (this year)-37.37%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-18.72%
P/E ratioNM
Price/Sales192.40
Price/Book5.16

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc-0.27-2.48%
ALKSAlkermes Plc-2.10-4.30%
JAZZJazz Pharmaceuticals...-2.75-2.19%
SGENSeattle Genetics Inc-2.04-3.69%
Data as of 09/29/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$1.15
Annual revenue (last year)$41.1M
Annual profit (last year)-$290.1M
Net profit margin-705.83%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts